Pioneer Fil-Med Limited IPO

IPO Details

• Open date: TBA
• Close Date: TBA
• Minimum Investment: To be updated
• Lot Size: TBA
• Price Range: TBA
• Listing: BSE, NSE
• Issue Size: ₹5,000 million (Fresh ₹2,500 million + OFS ₹2,500 million)
• Listing Date: TBA

IPO Timeline

• Bidding Start: TBA
• Bidding Ends: TBA
• Allotment Finalisation: TBA
• Refund Initiation: TBA
• Demat Transfer: TBA
• Listing: TBA

About Pioneer Fil-Med Limited

Incorporated in 1997, Pioneer Fil-Med Limited manufactures railway and metro equipment, including traction motors, alternators, brake discs, gangways, platform screen doors, and filters for locomotive and coach applications. The company is an approved Category-I supplier to Indian Railways for traction alternators, traction motors, HHP 4500 motors, brake discs, and filters. It has diversified into renewable energy, supplying wind generators. Operating three facilities in Bawal and Manesar, Haryana, the company serves railways, metro corporations, and wind turbine manufacturers with a workforce of 141 as of December 31, 2025.

Pioneer Fil-Med Limited IPO Overview

Pioneer Fil-Med Limited filed its DRHP with SEBI on March 29, 2026, for a book-built IPO aggregating up to ₹5,000 million, comprising a fresh issue of ₹2,500 million and an offer for sale of ₹2,500 million. The company may consider a pre-IPO placement. Net proceeds from the fresh issue will be utilized for part financing a gear box manufacturing facility (₹1,022.67 million), a wind generator components manufacturing facility (₹795.04 million), and general corporate purposes. Promoters are Pioneer Facor IT Infradevelopments, Pioneer Procon, Pioneer Securities, and Pioneer Fincap, holding 95% pre-issue. Lead manager: Nuvama Wealth Management Ltd. Registrar: MUFG Intime India Pvt. Ltd. Listing on BSE and NSE. IPO dates, price band, and lot size are yet to be announced.

Pioneer Fil-Med Limited Upcoming IPO Details

Category	Details
Issue Type	Book Built Issue IPO
Total Issue Size	[.] shares (aggregating up to ₹500 Cr)
Fresh Issue	[.] shares (aggregating up to ₹250 Cr)
Offer for Sale (OFS)	[.] shares of ₹10 (aggregating up to ₹250 Cr)
IPO Dates	TBA
Price Bands	TBA
Lot Size	TBA
Face Value	₹10 per share
Listing Exchange	BSE, NSE
Shareholding pre-issue	2,55,33,600 shares
Shareholding post-issue	TBA

IPO Lots

Application	Lots	Shares	Amount
Retail (Min)	TBA	TBA	TBA
Retail (Max)	TBA	TBA	TBA
S-HNI (Min)	TBA	TBA	TBA
S-HNI (Max)	TBA	TBA	TBA
B-HNI (Min)	TBA	TBA	TBA

Pioneer Fil-Med Limited IPO Reservation

Investor Category	Shares Offered
QIB Shares Offered	Not more than 50% of the Net Offer
Retail Shares Offered	Not less than 35% of the Net Offer
NII (HNI) Shares Offered	Not less than 15% of the Net Offer

Pioneer Fil-Med Limited IPO Valuation Overview

KPI	Value
Earnings Per Share (EPS)	₹8.71
Price/Earnings (P/E) Ratio	TBD
Return on Net Worth (RoNW)	14.74%
Net Asset Value (NAV)	₹63.42/share
Return on Equity (RoE)	14.74%
Return on Capital Employed (RoCE)	16.95%
EBITDA Margin	23.89%
PAT Margin	16.28%
Debt-to-Equity Ratio	0.10x

Objectives of the IPO Proceeds

The net proceeds from the Fresh Issue are intended to be utilised as follows:

Particulars	Amount (₹ in million)
Part financing cost of establishing gear box manufacturing facility at Salarpur, Bhiwadi, Rajasthan	1,022.67
Part financing cost of establishing wind generator components manufacturing facility at Salarpur, Bhiwadi, Rajasthan	795.04
General corporate purposes*	[●]

*To be determined upon finalisation of the Offer Price. General corporate purposes shall not exceed 25% of gross proceeds.

Pioneer Fil-Med Limited Financials (₹ in million)

Particulars	30 Sep 2025	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	2,961.48	2,254.85	1,811.86	1,518.79
Revenue from Operations	1,560.63	3,264.18	2,329.80	860.67
Profit After Tax	254.06	404.38	263.91	111.72
Reserves and Surplus	1,364.28	1,141.88	771.97	542.70
Total Borrowings	188.68	185.45	85.08	218.03
Total Liabilities	1,057.64	605.20	561.03	531.90

Financial Status of Pioneer Fil-Med Limited

SWOT Analysis of Pioneer Fil-Med Limited

Strengths	Opportunities
Established manufacturer in high-entry-barrier railway traction equipment segment	Domestic traction equipment market projected to reach ₹32.6B by FY2030 (CAGR 13.4%)
Among top 3 Category-I approved suppliers for traction alternators to Indian Railways	Indian wind turbine components market to grow at 17.8% CAGR to ₹198.6B by FY2030
Category-I approved for traction motors, HHP 4500 motors, brake discs and filters	Government’s focus on railway electrification and Vande Bharat fleet expansion
Long-standing customer relationship with Indian Railways for over two decades	Expansion into high-value products like wheel-mounted brake discs and propulsion systems
Integrated manufacturing facilities with advanced machinery and in-house engineering	Platform screen door market growth driven by new metro projects and retrofitting
Experienced promoters with collective industry experience of over 7 decades	ALMM-wind framework creating opportunities for certified wind component manufacturers
Strong financial performance with revenue CAGR of 94.75% from FY23 to FY25	Make in India and Atmanirbhar Bharat initiatives favouring domestic manufacturers
Diversified into renewable energy with wind generators, adding second growth pillar	Offshore wind energy projects opening new avenues for component supply
Closing order book of ₹4,417.62 million as of September 30, 2025	Long-term maintenance and refurbishment contracts for PSD systems
High dependence on Indian Railways for revenue (over 95% of railway segment)	Intense competition from larger players like Titagarh Rail Systems, Siemens, ABB
Geographic concentration with all manufacturing facilities in Haryana	Regulatory changes in railway procurement policies and vendor approval processes
Recent diversification into wind energy still at nascent stage (2.78% of H1 FY26 revenue)	Cyclicality in government infrastructure spending affecting order inflows
Significant working capital intensity with net working capital days of 374 (Sep 2025)	Technology obsolescence requiring continuous R&D investment
Decline in ROCE from 28.79% (Sep 2025) to 13.59% (FY2025) – need to verify; but as per KPI table Sep 2025 ROCE is 28.79% (not annualised) and FY2025 is 13.59% – indicates seasonality?	Fluctuations in raw material prices (copper, steel, aluminium) impacting margins
Moderate scale compared to global peers like Wabtec and Knorr-Bremse	Delays in project execution and payment cycles from government customers
High promoter holding of 95% with limited public float	Geopolitical risks affecting import of specialised components
New facilities under construction (Salarpur) yet to become operational	Competition from Chinese manufacturers in wind generator components
Customer concentration risk – top customer contributed significant portion of revenue	Slowdown in metro rail project approvals affecting PSD business

Pioneer Fil-Med Limited IPO Strengths

Established Manufacturer in Select High-Entry-Barrier Segments of Locomotive Traction Equipment

Pioneer Fil-Med Limited is an established manufacturer and supplier of railway and metro equipment, with a strong presence across both diesel-electric and electric platforms. The domestic traction equipment segment is projected to reach ₹32.6 billion by Fiscal 2030, growing at a CAGR of 13.4%. The supply of traction systems is subject to rigorous testing, certification, and validation requirements mandated by railway authorities, creating significant barriers to entry and ensuring high standards of safety and reliability.

Category-I Approved Supplier to Indian Railways for Critical Products

Pioneer Fil-Med Limited is among the top three Category-I approved suppliers for traction alternators and holds Category-I approvals for traction motors, HHP 4500 traction motors, brake discs, and filters. These approvals reflect compliance with stringent qualification and testing standards of Indian Railways. Being an approved supplier provides a competitive moat, as new entrants must undergo lengthy validation processes. The company has successfully executed contracts for platform screen doors for metro rail corporations as well.

Integrated Manufacturing Facilities Supported by In-House Engineering and Product Development

Pioneer Fil-Med Limited operates three manufacturing facilities in Bawal and Manesar, Haryana, equipped with advanced machinery including horizontal machine centers, vertical turning lathes, vacuum pressure impregnation plants, coordinate measuring machines, and test benches. The company has developed several special-purpose machines for critical operations such as winding, assembly, balancing, and testing. In-house engineering capabilities enable product design, prototyping, and testing, supporting a comprehensive product portfolio including traction motors, alternators, brake discs, stators, rotors, and wind generators.

Long-Standing Customer Relationship with Indian Railways for Over Two Decades

Pioneer Fil-Med Limited has cultivated long-standing relationships with Indian Railways spanning more than two decades. The company prioritizes understanding of customer requirements and coordinates closely during product development and validation processes. Railways have been a repeat customer for its products for over 20 years, reflecting enduring reliability and deep-rooted partnership. This relationship provides revenue stability, repeat orders, and a strong foundation for introducing new products like wheel-mounted brake discs for Vande Bharat trains.

Experienced Management Team and Qualified Personnel with Significant Industry Experience

Pioneer Fil-Med Limited is guided by promoters Sushil Kumar Jain (over 34 years of experience in the locomotive industry), Anil Kumar Agarwal (28 years), Rishabh Jain (Chartered Accountant), and Akshat Agarwal (3 years). The management team includes qualified professionals across business development, finance, supply chain, and operations. The collective experience of promoters and senior leadership has been instrumental in scaling operations, fostering international collaborations, and bringing advanced products to the Indian market.

Track Record of Profitability and Consistent Financial Performance

Pioneer Fil-Med Limited has demonstrated strong financial performance, with revenue growing at a CAGR of 94.75% from FY2023 to FY2025, significantly outpacing the industry CAGR of 13.4%. EBITDA grew at a CAGR of 191.22% over the same period, with EBITDA margins improving from 7.88% in FY2023 to 17.62% in FY2025. PAT margins have remained consistently above 11%, with Return on Equity of 24.51% and Return on Capital Employed of 28.79% (for six months ended Sep 2025, annualised basis would be higher). The company maintains a low leverage position with Debt/Equity of 0.20.

Other IPO Pages Linking

More About Pioneer Fil-Med Limited

Pioneer Fil-Med Limited, incorporated in 1997, has evolved from a filter manufacturer to a comprehensive supplier of railway traction equipment and wind energy components.

Manufacturing Facilities

• Bawal Facility-I & II (Haryana): Equipped with horizontal machine centers, VTL, VPI plant, rotating ovens, CMM, and test benches for traction motors, alternators, stators, rotors, brake discs, and filters.
• Manesar Facility (Haryana): Manufactures platform screen doors, wind generators, rotor shafts, flexible gangway, wheel set guide, and suspension tubes.
• Salarpur, Bhiwadi, Rajasthan (under construction): Planned for gear box manufacturing and wind generator components (funded by IPO proceeds).

Product Portfolio

• Railway & Metro: Traction motors, traction alternators, brake discs, gangways, stators, rotors, platform screen doors, filters, motor suspension units, wheel set guides.
• Wind Energy: Wind generators (117 sets supplied to a leading wind turbine manufacturer between Oct 2025 – Feb 2026), with plans to expand into gearboxes and converters.
• Under Development: Complete axle box, gangway for Vande Bharat/Amrit Bharat coaches, gear case, retention tanks for LHB coaches, IGBT-based propulsion systems, wheel-mounted discs.

Customer and Approvals

• Category-I approved supplier to Indian Railways for traction alternators (top 3), traction motors, HHP 4500 motors, brake discs, and filters.
• Successfully executed platform screen door contracts for metro rail corporations (21 stations) and awarded additional contract.
• Order book: ₹4,417.62 million as of September 30, 2025 (91.59% from railways and metro, 8.41% from wind generators).
• Revenue breakdown (H1 FY2026): Locomotive equipment 96.07%, wind generators 1.85%, others 2.08%.

Subsidiaries and Joint Ventures

• No material subsidiaries as per DRHP. The company has a joint venture but no profit share in recent years.

Industry Outlook

India’s railway traction equipment market is experiencing robust growth driven by network electrification and fleet modernisation. According to the 1Lattice Report cited in the DRHP, the domestic traction equipment market is projected to reach ₹32.6 billion by Fiscal 2030, growing at a CAGR of 13.4% over Fiscal 2025–2030.

Key Growth Drivers for Railway Equipment:

• Electrification: Indian Railways targets 100% electrification, driving demand for electric locomotives and traction propulsion systems.
• Vande Bharat Expansion: Fleet expansion of Vande Bharat trains requires advanced traction motors, brake discs, gangways, and propulsion systems.
• Metro Rail Projects: Metro rail networks across Delhi, Mumbai, Ahmedabad, Chennai, Bengaluru, and Tier-II cities are progressively incorporating platform screen doors, especially in underground stations.
• Rolling Stock Modernisation: Replacement of ageing fleets with modern, energy-efficient locomotives and coaches.
• Localisation Mandates: “Make in India” and “Atmanirbhar Bharat” policies encourage domestic manufacturing of railway components.

Wind Energy Components Market:

• The Indian wind turbine components market expanded from ₹42.1 billion in Fiscal 2020 to ₹87.6 billion in Fiscal 2025 (CAGR 15.8%).
• Projected to reach ₹198.6 billion by Fiscal 2030, growing at a CAGR of 17.8%.
• By component: Gearbox (₹43.2 billion in FY2025) dominates, followed by converter (₹27.1 billion) and generator (₹17.3 billion).
• Policy support: National Wind-Solar Hybrid Policy, ALMM-wind framework, renewable purchase obligations, and offshore wind energy targets.

Platform Screen Door Market:

• Driven by new metro projects and retrofitting requirements in existing corridors.
• Increasing emphasis on unattended train operations and air-conditioned underground stations strengthens long-term demand.

How Will Pioneer Fil-Med Limited Benefit

• Pioneer Fil-Med Limited is poised to benefit from the domestic traction equipment market growing at 13.4% CAGR to ₹32.6 billion by FY2030, with the company already among the top 3 Category-I approved suppliers for traction alternators to Indian Railways.
• The company’s expansion into wind generator components positions it to capture the Indian wind turbine components market, which is projected to grow at 17.8% CAGR to ₹198.6 billion by FY2030, with generator segment alone estimated at ₹42.2 billion.
• With a closing order book of ₹4,417.62 million as of September 30, 2025 (2.83 times trailing annual revenue), the company has strong revenue visibility and execution pipeline over the next 12-18 months.
• The proposed gear box manufacturing facility (₹1,022.67 million investment) will allow the company to enter the largest sub-segment of the wind components market (gearbox valued at ₹93.7 billion by FY2030), significantly expanding its addressable market.
• Platform screen door business offers growth from both new metro projects and retrofitting, with the company already having successfully executed contracts for 21 stations and securing additional orders, creating recurring maintenance revenue streams.
• The company’s low debt-to-equity ratio of 0.20 and strong cash flows provide financial flexibility to fund expansion without over-leveraging, while the IPO proceeds will further strengthen the balance sheet.
• With product development pipeline including wheel-mounted brake discs for Vande Bharat, IGBT-based propulsion systems, and complete axle boxes, the company is well-positioned to increase content per locomotive and deepen customer relationships.

Peer Group Comparison

Name of Company	Revenue (₹ in million)	Face Value (₹)	Basic EPS (₹)	NAV (₹)	P/E Ratio	RoNW (%)
Pioneer Fil-Med Limited	3,264.18	10	14.40	53.76	[●]	26.79%
Titagarh Rail Systems Limited	38,677.50	2	20.41	178.84	32.17	11.48%
Bharat Forge Limited	1,51,228.03	2	20.05	193.55	89.63	10.17%
ABB India Limited	1,21,883.10	2	88.32	333.85	71.11	26.46%
BEML Limited	40,222.23	10	35.12	346.64	45.85	10.13%
Siemens Limited	1,73,642.00	2	59.14	371.44	55.33	15.91%
CG Power and Industrial Solutions Ltd	99,086.60	2	6.38	20.73	114.02	30.76%
Hind Rectifiers Limited	6,553.67	10	21.64	93.15	66.36	23.21%
Global Peers
Wabtec Corporation (USD)	8,78,324.72	1.00	511.59	4,981.29	40.72	10.46%
Knorr-Bremse AG (EUR)	7,16,722.36		250.94	1,717.44	37.36	14.61%

Key Strategies for Pioneer Fil-Med Limited

Expansion of Wind Energy Equipment Business

Pioneer Fil-Med Limited aims to build a scalable manufacturing platform in the wind energy sector, leveraging India’s renewable energy targets and the ALMM-wind framework. The company has already supplied 117 sets of wind generators to a leading wind turbine manufacturer. It plans to expand product portfolio to include gearboxes, wind power converters, and other high-value sub-assemblies, using IPO proceeds to establish dedicated gear box and wind generator component facilities at Salarpur, Rajasthan, thereby creating a second growth pillar.

Product Diversification and Expansion in the Railway Sector

Pioneer Fil-Med Limited intends to strengthen its market position by developing new traction propulsion systems, alternators, and auxiliary electrical components. The company has initiated development of wheel-mounted brake discs for Vande Bharat trains, retention tanks, and platform screen doors. It aims to expand into adjacent higher-value traction-related products, increase localisation of critical components under “Make in India,” and deepen engagement with railways, metro corporations, and rolling stock manufacturers.

Operational Efficiency and Cost Optimization through Integrated Manufacturing

Pioneer Fil-Med Limited aims to continuously improve profitability through backward integration, increased capacity utilisation, and process optimization. The company is constructing a new facility at Salarpur, Bhiwadi, Rajasthan, expected to operationalise by September 2026, for manufacturing LHB coach bogies and Vande Bharat bogies. It is integrating technology-driven solutions for real-time monitoring, predictive maintenance, and automation to reduce production costs, debottleneck critical processes, and minimise scrap, thereby achieving economies of scale.

Expansion of Platform Screen Doors Business

Pioneer Fil-Med Limited positions itself as a technically competent PSD solution provider through collaboration with international partners for specialised technology. The company intends to develop in-house capability for system integration, synchronisation with rolling stock door operations, and signalling systems. It plans phased localisation of manufacturing for structural modules, door mechanisms, and control panels, and expand into retrofit projects and long-term maintenance services, creating recurring revenue streams over the lifecycle of installed PSD systems.

FAQs

How can I apply for Pioneer Fil-Med Limited IPO?

You can apply via HDFCSky using UPI-based ASBA (Application Supported by Blocked Amount).

What is the total issue size of the Pioneer Fil-Med Limited IPO?

The IPO is ₹5,000 million (₹500 crore), comprising fresh issue of ₹2,500 million and OFS of ₹2,500 million.

When is the Pioneer Fil-Med Limited IPO opening?

IPO dates including open, close, and listing are yet to be announced by the company.

On which exchanges will Pioneer Fil-Med Limited shares be listed?

The equity shares will be listed on both BSE and NSE.

How will Pioneer Fil-Med Limited use the IPO proceeds?

Proceeds will fund gear box facility (₹1,022.67 mn), wind generator components facility (₹795.04 mn), and general corporate purposes.

Infographic Content

Pioneer Fil-Med Limited IPO Highlights

Pioneer Fil-Med Limited is a Category-I approved supplier to Indian Railways for traction alternators, motors, brake discs, and filters, with integrated manufacturing facilities and a growing wind energy components business.

• Offer Size:₹5,000 million (Fresh Issue ₹2,500 million; OFS ₹2,500 million)
• Purpose:Net proceeds from fresh issue will be used for gear box manufacturing facility (₹1,022.67 mn), wind generator components facility (₹795.04 mn), and general corporate purposes.
• Financials (FY March 2025):Revenue ₹3,264.18 million; Profit After Tax ₹404.38 million; EPS ₹14.40
• Listing:Mainboard IPO on BSE & NSE